Oak Thistle LLC Takes $321,000 Position in Bath & Body Works, Inc. (NYSE:BBWI)

Oak Thistle LLC acquired a new position in Bath & Body Works, Inc. (NYSE:BBWI) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 8,269 shares of the company’s stock, valued at approximately $321,000.

Other hedge funds have also bought and sold shares of the company. True Wealth Design LLC lifted its holdings in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after buying an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt increased its position in Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Bath & Body Works during the third quarter valued at $39,000. TD Private Client Wealth LLC lifted its holdings in Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after acquiring an additional 331 shares during the period. Finally, Meeder Asset Management Inc. boosted its position in Bath & Body Works by 480.3% in the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,436 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $36.78 on Friday. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99. The firm’s 50 day moving average price is $36.30 and its 200-day moving average price is $33.68. The stock has a market cap of $7.97 billion, a P/E ratio of 8.97, a PEG ratio of 0.98 and a beta of 1.82.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same period in the previous year, the firm posted $0.48 EPS. Bath & Body Works’s revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, equities analysts expect that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date was Friday, November 22nd. Bath & Body Works’s payout ratio is presently 19.51%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on BBWI. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Morgan Stanley decreased their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research report on Thursday, November 21st. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $42.00 to $48.00 in a research report on Friday, January 10th. Barclays raised their target price on Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a report on Tuesday, November 26th. Finally, Piper Sandler boosted their price target on Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, Bath & Body Works presently has a consensus rating of “Moderate Buy” and an average target price of $43.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.